Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire
dc.contributor.author | Harrold, Leslie R. | |
dc.contributor.author | Mazor, Kathleen M. | |
dc.contributor.author | Negron, Amarie | |
dc.contributor.author | Ogarek, Jessica | |
dc.contributor.author | Firneno, Cassandra L. | |
dc.contributor.author | Yood, Robert A. | |
dc.date | 2022-08-11T08:09:24.000 | |
dc.date.accessioned | 2022-08-23T16:29:24Z | |
dc.date.available | 2022-08-23T16:29:24Z | |
dc.date.issued | 2013-09-01 | |
dc.date.submitted | 2013-05-17 | |
dc.identifier.citation | <p>Harrold LR, Mazor KM, Negron A, Ogarek J, Firneno C, Yood RA. Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire. Rheumatology (Oxford). 2013 Sep;52(9):1623-9. doi:10.1093/rheumatology/ket158. <a href="http://dx.doi.org/10.1093/rheumatology/ket158" target="_blank">Link to article on publisher's site</a></p> | |
dc.identifier.issn | 1462-0324 (Linking) | |
dc.identifier.doi | 10.1093/rheumatology/ket158 | |
dc.identifier.pmid | 23620554 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/37235 | |
dc.description.abstract | Objective. We sought to examine primary care providers' gout knowledge and reported treatment patterns in comparison with current treatment recommendations. Methods. We conducted a national survey of a random sample of US primary care physicians to assess their treatment of acute, intercritical and tophaceous gout using published European and American gout treatment recommendations and guidelines as a gold standard. Results. There were 838 respondents (response rate of 41%), most of whom worked in private practice (63%) with >16 years experience (52%). Inappropriate dosing of medications in the setting of renal disease and lack of prophylaxis when initiating urate-lowering therapy (ULT) accounted for much of the lack of compliance with treatment recommendations. Specifically for acute podagra, 53% reported avoidance of anti-inflammatory drugs in the setting of renal insufficiency, use of colchicine at a dose of ≤2.4 mg/day and no initiation of a ULT during an acute attack. For intercritical gout in the setting of renal disease, 3% would provide care consistent with the recommendations, including initiating a ULT at the appropriate dose with dosing titration to a serum urate level of ≤6 mg/dl and providing prophylaxis. For tophaceous gout, 17% reported care consistent with the recommendations, including ULT use with dosing titration to a serum urate level of ≤6 mg/dl and prophylaxis. Conclusion. Only half of primary care providers reported optimal treatment practices for the management of acute gout and | |
dc.language.iso | en_US | |
dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=23620554&dopt=Abstract">Link to Article in PubMed</a> | |
dc.relation.url | http://dx.doi.org/10.1093/rheumatology/ket158 | |
dc.subject | Gout | |
dc.subject | Primary Health Care | |
dc.subject | Gout knowledge | |
dc.subject | Medication use | |
dc.subject | Treatment practices | |
dc.subject | Clinical Epidemiology | |
dc.subject | Health Services Research | |
dc.subject | Musculoskeletal Diseases | |
dc.subject | Primary Care | |
dc.subject | Rheumatology | |
dc.title | Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire | |
dc.type | Journal Article | |
dc.source.journaltitle | Rheumatology (Oxford, England) | |
dc.source.volume | 52 | |
dc.source.issue | 9 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/meyers_pp/651 | |
dc.identifier.contextkey | 4151968 | |
html.description.abstract | <p>Objective. We sought to examine primary care providers' gout knowledge and reported treatment patterns in comparison with current treatment recommendations.</p> <p>Methods. We conducted a national survey of a random sample of US primary care physicians to assess their treatment of acute, intercritical and tophaceous gout using published European and American gout treatment recommendations and guidelines as a gold standard.</p> <p>Results. There were 838 respondents (response rate of 41%), most of whom worked in private practice (63%) with >16 years experience (52%). Inappropriate dosing of medications in the setting of renal disease and lack of prophylaxis when initiating urate-lowering therapy (ULT) accounted for much of the lack of compliance with treatment recommendations. Specifically for acute podagra, 53% reported avoidance of anti-inflammatory drugs in the setting of renal insufficiency, use of colchicine at a dose of ≤2.4 mg/day and no initiation of a ULT during an acute attack. For intercritical gout in the setting of renal disease, 3% would provide care consistent with the recommendations, including initiating a ULT at the appropriate dose with dosing titration to a serum urate level of ≤6 mg/dl and providing prophylaxis. For tophaceous gout, 17% reported care consistent with the recommendations, including ULT use with dosing titration to a serum urate level of ≤6 mg/dl and prophylaxis.</p> <p>Conclusion. Only half of primary care providers reported optimal treatment practices for the management of acute gout and</p> | |
dc.identifier.submissionpath | meyers_pp/651 | |
dc.contributor.department | Department of Orthopedics and Physical Rehabilitation | |
dc.contributor.department | Department of Medicine, Division of Rheumatology | |
dc.contributor.department | Meyers Primary Care Institute | |
dc.source.pages | 1623-9 |